Method for the production of substituted 2-(phenoxymethyl)-benzoic acids

Details for Australian Patent Application No. 2004303506 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Fiedler, Wolfgang; Hachtel, Jochen; Neises, Bernd

Agent Watermark

Pub. Number AU-A-2004303506

PCT Pub. Number WO2005/061427

Priority 103 60 525.8 22.12.03 DE

Filing date 22 December 2004

Wipo publication date 7 July 2005

International Classifications

C07C 51/09 (2006.01) Preparation of carboxylic acids or their salts, halides, or anhydrides - from carboxylic acid esters or lactones

C07C 51/347 (2006.01) Preparation of carboxylic acids or their salts, halides, or anhydrides - by reactions not involving formation of carboxyl groups

C07C 65/24 (2006.01) Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061427 Priority application(s): WO2005/061427

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303507-Bacteria support material

2004303504-Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders